Direct analytical sample quality assessment for biomarker investigation: Qualifying cerebrospinal fluid samples

CSF biomarker variability in the Alzheimer's Association quality control program

(2013) Niklas Mattsson et al.   Alzheimers & Dementia

Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates

(2013) Yong Seok Choi et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

(2013) Anja H. Simonsen et al.   JOURNAL OF NEUROSCIENCE METHODS

Joining forces to fight neurodegenerative diseases

(2013) The Lancet Neurology   LANCET NEUROLOGY

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

(2013) Jacob J Kennedy et al.   NATURE METHODS

Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis

(2013) Damiana Pieragostino et al.   PROTEOMICS

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

(2013) Anna Häggmark et al.   PROTEOMICS

Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update

(2012) Marta del Campo et al.   Biomarkers in Medicine

Identification of Evidence-Based Biospecimen Quality-Control Tools

(2012) Fotini Betsou et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The Biology/Disease-driven Human Proteome Project (B/D-HPP): Enabling Protein Research for the Life Sciences Community

(2012) Ruedi Aebersold et al.   JOURNAL OF PROTEOME RESEARCH

Characterization and stability of transthyretin isoforms in cerebrospinal fluid examined by immunoprecipitation and high-resolution mass spectrometry of intact protein

(2012) Keld Poulsen et al.   METHODS

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2011) Hugo Vanderstichele et al.   Alzheimers & Dementia

State of the Art in Preservation of Fluid Biospecimens

(2011) Allison Hubel et al.   BIOPRESERVATION AND BIOBANKING

The Human Proteome Project: Current State and Future Direction

(2011) Pierre Legrain et al.   MOLECULAR & CELLULAR PROTEOMICS

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

(2011) Richard J. Perrin et al.   PLoS One

Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

(2010) A.C. Kroksveen et al.   Journal of Proteomics

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Safety of Lumbar Puncture Procedures in Patients with Alzheimers Disease

(2009) E. Peskind et al.   Current Alzheimer Research

The Effect of Preanalytical Factors on Stability of the Proteome and Selected Metabolites in Cerebrospinal Fluid (CSF)

(2009) Therese Rosenling et al.   JOURNAL OF PROTEOME RESEARCH

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications

(2008) Sheng Pan et al.   JOURNAL OF PROTEOME RESEARCH

Serum cystatin C and the risk of Alzheimer disease in elderly men

(2008) J. Sundelof et al.   NEUROLOGY